Birdwatch Note
2024-04-30 05:29:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
This is false. AstraZeneca mentioned blood clots as a rare COVID vaccine side effect way back in 2021: https://www.astrazeneca.com/media-centre/press-releases/2021/vaxzevria-and-mrna-covid-19-vaccines-showed-similar-and-favourable-safety-profiles-in-a-population-based-cohort-study-of-over-a-million-people.html
Written by 80D6E5FA019B8E5525249A0659485ABEF36094C2007752792D4CD977DC311BA4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785137776780054991
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785179771212607582
- noteId - 1785179771212607582
- participantId -
- noteAuthorParticipantId - 80D6E5FA019B8E5525249A0659485ABEF36094C2007752792D4CD977DC311BA4 Participant Details
- createdAtMillis - 1714454999151
- tweetId - 1785137776780054991
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- This is false. AstraZeneca mentioned blood clots as a rare COVID vaccine side effect way back in 2021: https://www.astrazeneca.com/media-centre/press-releases/2021/vaxzevria-and-mrna-covid-19-vaccines-showed-similar-and-favourable-safety-profiles-in-a-population-based-cohort-study-of-over-a-million-people.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-30 05:29:59 UTC (1714454999151) |
2024-04-30 09:04:23 UTC (1714467863692) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
NEEDS_MORE_RATINGS | 2024-04-30 09:04:23 UTC (1714467863692) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-30 07:38:51 -0500 | Rating Details | |
| 2024-04-30 06:38:14 -0500 | Rating Details | |
| 2024-04-30 05:46:52 -0500 | Rating Details | |
| 2024-04-30 04:44:13 -0500 | Rating Details | |
| 2024-04-30 02:23:59 -0500 | Rating Details | |
| 2024-04-30 01:53:12 -0500 | Rating Details | |
| 2024-04-30 01:51:45 -0500 | Rating Details | |
| 2024-04-30 01:50:18 -0500 | Rating Details | |
| 2024-04-30 01:32:10 -0500 | Rating Details | |
| 2024-04-30 01:21:27 -0500 | Rating Details | |
| 2024-04-30 00:45:17 -0500 | Rating Details | |
| 2024-05-01 02:20:03 -0500 | Rating Details | |
| 2024-04-30 15:46:12 -0500 | Rating Details | |
| 2024-04-30 14:49:11 -0500 | Rating Details | |
| 2024-04-30 14:30:03 -0500 | Rating Details | |
| 2024-04-30 12:05:39 -0500 | Rating Details | |
| 2024-04-30 11:36:44 -0500 | Rating Details | |
| 2024-04-30 09:08:33 -0500 | Rating Details | |
| 2024-04-30 08:51:56 -0500 | Rating Details | |
| 2024-04-30 07:09:01 -0500 | Rating Details | |
| 2024-04-30 05:25:37 -0500 | Rating Details | |
| 2024-04-30 03:40:34 -0500 | Rating Details | |
| 2024-04-30 03:28:28 -0500 | Rating Details | |
| 2024-04-30 02:47:26 -0500 | Rating Details | |
| 2024-04-30 01:32:41 -0500 | Rating Details | |
| 2024-04-30 00:47:05 -0500 | Rating Details | |
| 2024-04-30 00:45:23 -0500 | Rating Details | |
| 2024-04-30 00:34:49 -0500 | Rating Details | |
| 2024-04-30 00:31:31 -0500 | Rating Details | |
| 2024-04-30 21:08:24 -0500 | Rating Details | |
| 2024-04-30 11:38:35 -0500 | Rating Details | |
| 2024-04-30 08:44:15 -0500 | Rating Details | |
| 2024-04-30 08:34:43 -0500 | Rating Details | |
| 2024-04-30 04:37:48 -0500 | Rating Details | |
| 2024-04-30 04:01:44 -0500 | Rating Details | |
| 2024-04-30 03:23:21 -0500 | Rating Details | |
| 2024-04-30 03:00:47 -0500 | Rating Details | |
| 2024-04-30 02:49:14 -0500 | Rating Details | |
| 2024-04-30 02:19:16 -0500 | Rating Details | |
| 2024-04-30 01:55:55 -0500 | Rating Details | |
| 2024-04-30 01:51:22 -0500 | Rating Details | |
| 2024-04-30 01:37:10 -0500 | Rating Details | |
| 2024-04-30 01:05:51 -0500 | Rating Details | |
| 2024-04-30 00:58:07 -0500 | Rating Details | |
| 2024-04-30 00:53:02 -0500 | Rating Details | |
| 2024-04-30 00:32:52 -0500 | Rating Details | |
| 2024-05-04 13:45:48 -0500 | Rating Details | |
| 2024-05-02 16:58:49 -0500 | Rating Details | |
| 2024-04-30 16:32:59 -0500 | Rating Details | |
| 2024-05-05 00:27:11 -0500 | Rating Details | |
| 2024-05-10 10:27:43 -0500 | Rating Details | |
| 2024-04-30 12:38:06 -0500 | Rating Details | |
| 2024-04-30 11:21:31 -0500 | Rating Details | |
| 2024-04-30 04:40:04 -0500 | Rating Details | |
| 2024-04-30 04:31:59 -0500 | Rating Details | |
| 2024-04-30 03:52:56 -0500 | Rating Details | |
| 2024-04-30 02:16:12 -0500 | Rating Details | |
| 2024-04-30 02:10:30 -0500 | Rating Details | |
| 2024-04-30 02:04:36 -0500 | Rating Details | |
| 2024-04-30 01:58:24 -0500 | Rating Details | |
| 2024-04-30 01:52:55 -0500 | Rating Details | |
| 2024-04-30 01:38:10 -0500 | Rating Details | |
| 2024-04-30 01:37:02 -0500 | Rating Details | |
| 2024-04-30 00:30:17 -0500 | Rating Details | |
| 2024-04-30 16:42:14 -0500 | Rating Details | |
| 2024-04-30 02:01:59 -0500 | Rating Details | |
| 2024-04-30 01:22:21 -0500 | Rating Details | |
| 2024-04-30 13:51:07 -0500 | Rating Details |